Research article
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
-
* Corresponding author: Michael A Cahill mike.cahill@arcor.de
1 Department of Obstetrics and Gynecology, University of Tuebingen, Calwerstraße, 72076 Tübingen, Germany
2 Current Address: Department of Surgery, Indiana University School of Medicine, W Walnut Street, Indianapolis, Indiana, 46202, USA
3 ProteoSys AG, Carl-Zeiss-Straße, 55129 Mainz, Germany
4 Department of Pathology, University of Tuebingen, Liebermeisterstraße, 72076 Tübingen, Germany
5 Current Address: Department of Pathology, Ludwig-Maximilians-University of Munich, Thalkirchnerstraße, 80337 Munich, Gemany
6 Current Address: Merck-Serono – Global Clinical Development Unit Oncology, Merck KGaA, Frankfurter Straße, 64293 Darmstadt, Germany
7 School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia
Breast Cancer Research 2008, 10:R85 doi:10.1186/bcr2155
See related editorial by Craven, http://breast-cancer-research.com/content/10/6/113
Published: 15 October 2008Additional files
Additional file 1:
Supplementary materials. Presented are Supplementary discussions entitled 'Validation of the differential abundance profile' and 'Candidate PGRMC1 interacting proteins'. It additionally contains two supplementary tables: Table S1 ('Protein spots that contained multiple identifications of individual proteins as gene products') and Table S2 ('Clinical patient data for the tumours in Figure 8B and 8C').
Format: PDF Size: 90KB Download file
This file can be viewed with: Adobe Acrobat Reader
